Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting
Ann Rheum Dis. 2021;80(9):1130-1136
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2021;80(9):1130-1136
Int J Rheum Dis. 2021. Epub ahead of print
Ann Rheum Dis. 2021 Jul 28:annrheumdis-2021-220651
RMD Open. 2021;7(2):e001621.
Clin Rheumatol. 2021. Epub ahead of print doi: 10.1007/s10067-021-05853-x
Arthritis Res Ther. 2021;23(1):197
Rheumatology (Oxford). 2021;60(7):3209–21
Auto Immun Highlights. 2021;12(1):8.
Ann Rheum Dis. 2021 May 28. DOI: 10.1136/annrheumdis-2021-220418
Clin Rheumatol. 2021 Jun 16. DOI: 10.1007/s10067-021-05815-3